Deutsche Bank Sticks to Its Buy Rating for Healthequity (HQY)

By Carrie Williams

In a report released today, George Hill from Deutsche Bank maintained a Buy rating on Healthequity (HQYResearch Report), with a price target of $57.00. The company’s shares closed last Monday at $42.02, close to its 52-week low of $36.48.

According to, Hill is a 4-star analyst with an average return of 1.4% and a 43.0% success rate. Hill covers the Services sector, focusing on stocks such as AmerisourceBergen, Molina Healthcare, and Cardinal Health.

Healthequity has an analyst consensus of Strong Buy, with a price target consensus of $63.75, implying a 55.8% upside from current levels. In a report issued on March 11, Wells Fargo also maintained a Buy rating on the stock with a $71.00 price target.

See today’s analyst top recommended stocks >>

Based on Healthequity’s latest earnings release for the quarter ending January 31, the company reported a quarterly GAAP net loss of $190K. In comparison, last year the company had a net profit of $13.12 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health planbs, brokers, consultants and financial advisors.